FLYNN JAMES E sold 13.2% of their position (740.15K shares) of ARS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $13.66M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/1/2025ACC: 0001193805-25-000959
Director10% OwnerOther
Since Nov 2022
-740.15K
Net shares
Net seller
$13.66M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
740.15K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−370.07K
Price / share
$18.46
Trade value
$6.83M
% of position
7.0%
6/27/2025
5.26M→4.89M
Class A Common Stock
Indirect
Shares
−370.07K
Price / share
$18.46
Trade value
$6.83M
% of position
7.0%
6/27/2025
5.26M→4.89M
Total
Net shares
−740.15K
Net value
-$13.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 6/27/2025 | S · Sale | −370.07K | $18.46 | $6.83M | 7.0% | 5.26M | 4.89M |
| Class A Common Stock Indirect | 6/27/2025 | S · Sale | −370.07K | $18.46 | $6.83M | 7.0% | 5.26M | 4.89M |
| Total | −740.15K | -$13.66M | ||||||
Derivative Transactions0
No derivative transactions reported